These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 8490203)
21. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Mellish KJ; Kelland LR; Harrap KR Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478 [TBL] [Abstract][Full Text] [Related]
22. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells. O'Neill CF; Hunakova L; Kelland LR Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899 [TBL] [Abstract][Full Text] [Related]
23. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line. Mauldin SK; Husain I; Sancar A; Chaney SG Cancer Res; 1986 Jun; 46(6):2876-82. PubMed ID: 3698013 [TBL] [Abstract][Full Text] [Related]
24. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells. Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681 [TBL] [Abstract][Full Text] [Related]
25. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand. Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030 [TBL] [Abstract][Full Text] [Related]
26. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV). Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice. Kido Y; Khokhar AR; Yoshida M; Thai GW; Siddik ZH Drug Metab Dispos; 1994; 22(2):312-7. PubMed ID: 8013287 [TBL] [Abstract][Full Text] [Related]
28. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines. Roberts JD; Peroutka J; Beggiolin G; Manzotti C; Piazzoni L; Farrell N J Inorg Biochem; 1999 Oct; 77(1-2):47-50. PubMed ID: 10626353 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II). Wilkoff LJ; Dulmadge EA; Trader MW; Harrison SD; Griswold DP Cancer Chemother Pharmacol; 1987; 20(2):96-100. PubMed ID: 3664938 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the effectivity of two diaminocyclohexane Pt-complexes. Balázová E; Hrubisko M; Ujházy V Neoplasma; 1985; 32(5):537-42. PubMed ID: 4069288 [TBL] [Abstract][Full Text] [Related]
31. The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (review). Chaney S Int J Oncol; 1995 Jun; 6(6):1291-305. PubMed ID: 21556672 [TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity and tolerance to DNA adducts of alicyclic mixed amine platinum(II) homologs in tumor models sensitive and resistant to cisplatin or tetraplatin. Yoshida M; Khokhar AR; Siddik ZH Oncol Rep; 1998; 5(5):1281-7. PubMed ID: 9683851 [TBL] [Abstract][Full Text] [Related]
33. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines. Mellish KJ; Barnard CF; Murrer BA; Kelland LR Int J Cancer; 1995 Sep; 62(6):717-23. PubMed ID: 7558420 [TBL] [Abstract][Full Text] [Related]
34. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells. Waud WR Cancer Res; 1987 Dec; 47(24 Pt 1):6549-55. PubMed ID: 3677093 [TBL] [Abstract][Full Text] [Related]
35. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity. Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207 [TBL] [Abstract][Full Text] [Related]
36. Coordination modes vs. antitumor activity: synthesis and antitumor activity of novel platinum(II) complexes of N-substituted amino dicarboxylic acids. Kim YS; Song R; Chung HC; Jun MJ; Sohn YS J Inorg Biochem; 2004 Jan; 98(1):98-104. PubMed ID: 14659638 [TBL] [Abstract][Full Text] [Related]
37. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O. Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801 [TBL] [Abstract][Full Text] [Related]
38. Drug resistance induction and cross-resistance studies with Pt-complexes. Hrubisko M; Balázová E; Ujházy V Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968 [TBL] [Abstract][Full Text] [Related]
39. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts. Goddard P; Valenti M; Kelland LR Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451 [TBL] [Abstract][Full Text] [Related]
40. The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. Nicolson MC; Orr RM; O'Neill CF; Harrap KR Neoplasma; 1992; 39(3):189-95. PubMed ID: 1528325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]